Showing results (141-150 of 164) with videos related to
Sort By:
Pageof 17
Cell Chemical Biology|December 28, 2024
Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screenBradley E Poulsen, Thulasi Warrier, Sulyman Barkho, et al.Plos Pathogens|May 16, 2017
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulenceAmy K Barczak, Roi Avraham, Shantanu Singh, et al.Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.Nature Communications|November 3, 2025
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosisAustin N Bond, Marek Orzechowski, Shuting Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignanciesEdmund C Lee, Michael Fitzgerald, Bret Bannerman, et al.G3 (Bethesda, Md.)|September 30, 2015
Genome Sequences of Three Phytopathogenic Species of the Magnaporthaceae Family of FungiLaura H Okagaki, Cristiano C Nunes, Joshua Sailsbery, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2006
Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studiesHilary Hoey, Hannah M McGee, Michael Fitzgerald, et al.Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agentQun Li, Keith W Woods, Akiyo Claiborne, et al.Cancer Discovery|February 26, 2021
Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung CancerFrancois Gonzalvez, Sylvie Vincent, Theresa E Baker, et al.Proceedings of the National Academy of Sciences of the United States of America|April 5, 2022
Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacyEun-Ik Koh, Peter O Oluoch, Nadine Ruecker, et al.Pageof 17